发现好书期刊，享受阅读乐趣

海量图书期刊资源，随时随地畅享阅读乐趣

Certolizumab pegol is effective for chronic plaque psoriasis across patient subgroups: A pooled subanalysis from ongoing phase 3 studies (CIMPASI-1, CIMPASI-2, and CIMPACT)

Certolizumab pegol is effective for chronic plaque psoriasis across patient subgroups: A pooled subanalysis from ongoing phase 3 studies (CIMPASI-1, CIMPASI-2, and CIMPACT)

期刊名称Journal of the American Academy of Dermatology
卷第79卷
期第3期
印刷ISSN0190-9622
文件大小111.74KB
发表时间2018-09
DOI10.1016/j.jaad.2018.05.301

← 返回【学霸图书馆】主页